Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
FS120 Phase 1/1b Study in Patients With Advanced Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center
- Status
- UNKNOWN
- Phase
- NA
Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Imaging of Solid Tumors Using FAP-2286
- Status
- RECRUITING
- Phase
- PHASE1
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)
- Status
- COMPLETED
- Phase
- N/A
Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2
- Status
- UNKNOWN
- Phase
- N/A
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ARREST - A Phase I Study of SABR for Poly-metastatic Disease
- Status
- COMPLETED
- Phase
- NA
Combined Deep Inspiration Breath Hold (DIBH)-Expiration Planning Technique in Patients With Lung Tumors in Close Proximity to the Chest Wall
- Status
- COMPLETED
- Phase
- NA
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Systemic Chemotherapy Plus PD-1 for Metastasis ICC
- Status
- WITHDRAWN
- Phase
- PHASE2
Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC
- Status
- COMPLETED
- Phase
- PHASE2
Optimizing Y90 Therapy for Radiation Lobectomy
- Status
- RECRUITING
- Phase
- N/A